0001127602-22-012857.txt : 20220502 0001127602-22-012857.hdr.sgml : 20220502 20220502164055 ACCESSION NUMBER: 0001127602-22-012857 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220428 FILED AS OF DATE: 20220502 DATE AS OF CHANGE: 20220502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nader Francois CENTRAL INDEX KEY: 0001365343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 22882653 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-04-28 0001682852 Moderna, Inc. MRNA 0001365343 Nader Francois C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Common Stock 2022-04-28 4 M 0 703 0 A 703 D Restricted Stock Units 0 2022-04-28 4 M 0 703 0 D Common Stock 703 0 D Stock Option (Right to Buy) 142.52 2022-04-28 4 A 0 5415 0 A Common Stock 5415 5415 D Restricted stock units convert into common stock on a one-for-one basis. The shares subject to this restricted stock unit award vested in full on April 28, 2022. This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. /s/ Brian Sandstrom, as Attorney-in-Fact 2022-05-02